13 Patents
- 0 cites
- 0 cites
- US122915122025Oxime Compounds as Agonists of the Muscarinic M 1 And/or M 4 Receptor
Nxera Pharma UK Limited
0 cites - 0 cites
- US122150992025Quinolinone and Benzoxazine Derivatives as Muscarinic M 1 And/or M 4 Receptor Agonists
Nxera Pharma UK Limited
0 cites - 0 cites
- 0 cites
- US119458012024Bicyclic Aza Compounds as Muscarinic M 1 And/or M 4 Receptor Agonists
Allergan Pharmaceuticals International Limited
0 cites - US118344072023Substituted Cyclohexanes as Muscarinic M1 Receptor And/or M4 Receptor Agonists
Heptares Therapeutics Limited
0 cites - 0 cites
- 0 cites
- US116800532023Methods of Treatment Using 4-(3-cyanophenyl)-6-pyridinylpyrimidine Mglu5 Modulators
Heptares Therapeutics Limited
0 cites - US115847322023Methods of Treatment Using 4-(3-cyanophenyl)-6-pyridinylpyrimidine Mglu5 Modulators
Heptares Therapeutics Limited
0 cites